Stock Research

Stock Quotes & Research Tools

Resmed Inc RMD:NYSE
Last PriceToday's ChangeToday's Volume
$203.15-0.73 (-0.36%)715,022Average
As of 7:00pm ET, 07/19/2024
Company Performance
Today's Open$206.94
Previous Close$203.88
Day's Range$202.76 - $207.62
52 Week range$132.24 - $229.97
Avg. Volume (10 Day)787,673
Put/Call Ratio (1 Day)0.8
Put/Call Ratio (30 Day)1.3
Quarterly Div. (Ann. Yield)$0.48 (0.95%)
Next Ex-DateMay 08, 2024
Next Pay DateJun 13, 2024
Market Capitalization (Mid Cap)$29.8B
Shares Outstanding146.9M
Shares Held By Institutions56%
Headlines for Jul 20, 2024
There are no headlines for Jul 20, 2024
Additional Company News Providers
Company Headlines
  • Form 4 RESMED INC For: Jul 08 Filed by: Farrell Michael J.
  • Form 4 RESMED INC For: Jul 08 Filed by: Sandercock Brett
  • Form 144 RESMED INC Filed by: Farrell Michael J.
Press Releases
  • ResMed to Report Fourth Quarter Fiscal 2024 Earnings on August 1, 2024
  • PAP Therapy Reduces Hospitalizations by 31% and ER Visits by 23% for People with Obstructive Sleep Apnea and Comorbid Insomnia
  • Developed in Collaboration with Leading Scientists, New ResMed-Supported Research at ATS 2024 Provides Evidence of the Effectiveness and Critical Role of Positive Airway Pressure Therapy
Edgar Filings
  • Form 4 RESMED INC For: Jul 08 Filed by: Farrell Michael J.
  • Form 4 RESMED INC For: Jul 08 Filed by: Sandercock Brett
  • Form 144 RESMED INC Filed by: Farrell Michael J.
Research Provider Offering
Schwab's Variety of Detailed Stock Reports Help Investors Make Better Decisions

View the rationale behind our Schwab Equity Rating with details on what factors and components contribute to the overall rating.

Schwab Equity Rating Scale

Qualitative analysis on Morningstar’s global equity coverage. Analyst commentary, star ratings and economic moat evaluations.

Morningstar’s Rating Scale

This report contains the Argus rating and qualitative assessment of a stock's investment potential.

Argus 12 Month Rating Scale
Argus 5 Year Rating Scale

CFRA's Stock Reports contain equity analysis covering 5,000 publicly traded companies. The reports provide CFRA's ranking and qualitative opinion, financial statistics, and up to 10 years of summary balance sheet and income statement data.

CFRA's Opinion Scale
S&P Global's Earnings & Dividends Rank Scale

Detailed financials and consensus ratings from Refinitiv.

Refinitiv Stock Reports Plus

Manage market risk with quantitative technical analysis models from Market Edge.

Market Edge Second Opinion™ Weekly Rating Scale
Market Edge Second Opinion Score™ Scale
New to Schwab?
  or call 800-435-4000
Already a Schwab Client?
  to view our full client offering

Quotes are delayed by at least 15 minutes. Before trading, please check a real-time quote for current information.

Important Disclosures

Schwab Equity Ratings and other materials are for informational purposes only and is not an offer to sell or the solicitation of an offer to buy. Schwab Equity Ratings and the general buy/sell/hold guidance are not personal recommendations for any particular investor or client and do not take into account the financial, investment or other objectives or needs of, and may not be suitable for any particular investor or client. Before buying, investors and clients should consider whether the investment is suitable. Investors and clients should consider Schwab Equity Ratings as only a single factor in making their investment decision while taking into account the current market environment.

Schwab Equity Ratings utilize third-party data in the forming of a rating. Data is obtained from what are considered reliable sources; however, its accuracy, completeness or reliability cannot be guaranteed. Schwab Equity Ratings are generally updated weekly, so you should review and consider any recent market or company news before taking any action. Stocks may go down as well as up and investors (including clients) may lose money, including their original investment. Past performance is no indication of future results and returns are not guaranteed. For individualized advice, please contact Schwab at 1 (877) 284-9817. Note: An asterisk (*) next to a Schwab Equity Rating means that a potentially significant even has been announced for an A or B rated stock, Although Schwab generally does not monitor C, D, and F rated stocks for current news, from time to time, asterisks may appear on a particular stock due to certain circumstances (e.g. the downgrade of a stock from a B to C rating).

The news sources used on come from independent third parties. Schwab is not affiliated with any of the news content providers. Schwab is not responsible for the content, and does not write or control which particular article appears on its website. The securities markets (1) reserve all rights to the market data that they make available; (2) do not guarantee that data; and (3) shall not be liable for any loss due either to their negligence or to any cause beyond their reasonable control.

(0811-4793, 1214-7049)